Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
L. Sherlock, D.E.F. Mckeegan, Z. Cheng, C.M. Wathes & D.C. Wathes. (2012) Effects of contact dermatitis on hepatic gene expression in broilers. British Poultry Science 53:4, pages 439-452.
Read now
Read now
Juejin Wang, Lai Jin, Jie Chen & Shengnan Li. (2009) Activation of Corticotropin-Releasing Factor Receptor 2 Inhibits the Growth of Human Small Cell Lung Carcinoma Cells. Cancer Investigation 28:2, pages 146-155.
Read now
Read now
Articles from other publishers (35)
Angélica Araceli Ramírez-Guerrero, Christian Octavio González-Villaseñor, Evelia Leal-Ugarte, Melva Gutiérrez-Angulo, Mario Ramírez-Flores, Iván Delgado-Enciso & Nelly Margarita Macías-Gómez. (2023)
Association between Genetic Variant rs2267716 of
CRHR2
Gene with Colorectal Cancer
. Journal of Investigative Medicine 70:4, pages 947-952.
Crossref
Crossref
Pouriya Faraj Tabrizi, Anahit Mohebbi Tafrechi, Inga Peters, Faranaz Atschekzei, Markus Antonius Kuczyk, Jürgen Serth & Hossein Tezval. (2019) Cancer-Specific Loss of Urocortin 3 in Human Renal Cancer. Advances in Therapy 37:1, pages 288-299.
Crossref
Crossref
Hossein Tezval, Natalia Dubrowinskaja, Inga Peters, Christel Reese, Katrin Serth, Faranaz Atschekzei, J?rg Hennenlotter, Arnulf Stenzl, Markus A. Kuczyk & J?rgen Serth. (2016) Tumor Specific Epigenetic Silencing of Corticotropin Releasing Hormone -Binding Protein in Renal Cell Carcinoma: Association of Hypermethylation and Metastasis. PLOS ONE 11:10, pages e0163873.
Crossref
Crossref
Caterina Squillacioti, Adriana De Luca, Giovanna Liguori, Sabrina Al?Giuseppe Germano, Giuseppe Vassalotti, Luigi Navas & Nicola Mirabella. (2016) Urocortinergic system in the testes of normal and cryptorchid dogs. Annals of Anatomy - Anatomischer Anzeiger 207, pages 91-96.
Crossref
Crossref
Jorge A. Rodriguez, Sara Huerta-Yepez, Ivy Ka Man Law, Guillermina J. Baay-Guzman, Belen Tirado-Rodriguez, Jill M. Hoffman, Dimitrios Iliopoulos, Daniel W. Hommes, Hein W. Verspaget, Lin Chang, Charalabos Pothoulakis & Stavroula Baritaki. (2015) Diminished Expression of Corticotropin-Releasing Hormone Receptor 2 in Human Colon Cancer Promotes Tumor Growth and Epithelial-to-Mesenchymal Transition via Persistent Interleukin-6/Stat3 Signaling. Cellular and Molecular Gastroenterology and Hepatology 1:6, pages 610-630.
Crossref
Crossref
Sang Hoon Rhee, Elise L. Ma, Yunna Lee, Yvette Taché, Charalabos Pothoulakis & Eunok Im. (2015) Corticotropin Releasing Hormone and Urocortin 3 Stimulate Vascular Endothelial Growth Factor Expression through the cAMP/CREB Pathway. Journal of Biological Chemistry 290:43, pages 26194-26203.
Crossref
Crossref
Daniel Wai-Hung Ho, Alan Ka-Lun Kai & Irene Oi-Lin Ng. (2015) TCGA whole-transcriptome sequencing data reveals significantly dysregulated genes and signaling pathways in hepatocellular carcinoma. Frontiers of Medicine 9:3, pages 322-330.
Crossref
Crossref
Omair Anwar Mohiuddin & Chris Biggs. (2015) Evaluation of the effect of natural peptide 'Urocortin' on corticotrophin releasing factor (CRF) receptor expression in ND7/23 cells. Brazilian Journal of Pharmaceutical Sciences 51:1, pages 233-239.
Crossref
Crossref
Shu Xu, QiuYi Wu, Gang Guo & XinSheng Ding. (2015) The protective effects of urocortin1 against intracerebral hemorrhage by activating JNK1/2 and p38 phosphorylation and further increasing VEGF via corticotropin-releasing factor receptor 2. Neuroscience Letters 589, pages 31-36.
Crossref
Crossref
Eunok Im. (2015) Multi-facets of Corticotropin-releasing Factor in Modulating Inflammation and Angiogenesis. Journal of Neurogastroenterology and Motility 21:1, pages 025-032.
Crossref
Crossref
Marjolaine A. Pelissier-Rota, Nicolas T. Chartier & Muriel R. Jacquier-Sarlin. 2015. Intercellular Communication in Cancer. Intercellular Communication in Cancer
53
149
.
Chao Zhu, Zongxing Sun, Chuanhua Li, Rui Guo, Li Li, Lai Jin, Rong Wan & Shengnan Li. (2014) Urocortin affects migration of hepatic cancer cell lines via differential regulation of cPLA2 and iPLA2. Cellular Signalling 26:5, pages 1125-1134.
Crossref
Crossref
L. Jin, C. Li, R. Li, Z. Sun, X. Fang & S. Li. (2014) Corticotropin-releasing hormone receptors mediate apoptosis via cytosolic calcium-dependent phospholipase A2 and migration in prostate cancer cell RM-1. Journal of Molecular Endocrinology 52:3, pages 255-267.
Crossref
Crossref
Lai Jin, Jiandong Chen, Li Li, Chuanhua Li, Cheng Chen & Shengnan Li. (2014) CRH suppressed TGFβ1-induced Epithelial–Mesenchymal Transition via induction of E-cadherin in breast cancer cells. Cellular Signalling 26:4, pages 757-765.
Crossref
Crossref
Eunok Im. (2014) Corticotropin-releasing Hormone and Its Biological Diversity toward Angiogenesis. Intestinal Research 12:2, pages 96.
Crossref
Crossref
Hossein Tezval, Faranaz Atschekzei, Inga Peters, Sandra Waalkes, J?rg Hennenlotter, Arnulf Stenzl, Jan U Becker, Axel S Merseburger, Markus A Kuczyk & J?rgen Serth. (2013) Reduced mrna expression level of corticotropin-releasing hormone-binding protein is associated with aggressive human kidney cancer. BMC Cancer 13:1.
Crossref
Crossref
Sae Hwan Lee, Young‐Hwa Chung, Jeong A. Kim, Danbi Lee, Young‐Joo Jin, Ju Hyun Shim, Myoung‐Kuk Jang, Eun‐Young Cho, Eun‐Soon Shin, Jong‐Eun Lee, Neung Hwa Park, Eunsil Yu & Young Joo Lee. (2011) Single nucleotide polymorphisms associated with metastatic tumour antigen 1 overexpression in patients with hepatocellular carcinoma. Liver International 32:3, pages 457-466.
Crossref
Crossref
Lai Jin, Qichun Zhang, Rui Guo, Lina Wang, Juejin Wang, Rong Wan, Rongjian Zhang, Youhua Xu & Shengnan Li. (2011) Different effects of corticotropin-releasing factor and urocortin 2 on apoptosis of prostate cancer cells in vitro. Journal of Molecular Endocrinology 47:2, pages 219-227.
Crossref
Crossref
Theophilus I. Emeto, Joseph V. Moxon, Catherine Rush, Lynn Woodward & Jonathan Golledge. (2011) Relevance of urocortins to cardiovascular disease. Journal of Molecular and Cellular Cardiology 51:3, pages 299-307.
Crossref
Crossref
P. M. Jamieson, M. E. Cleasby, Y. Kuperman, N. M. Morton, P. A. T. Kelly, D. G. Brownstein, K. J. Mustard, J. M. Vaughan, R. N. Carter, C. N. Hahn, D. G. Hardie, J. R. Seckl, A. Chen & W. W. Vale. (2011) Urocortin 3 transgenic mice exhibit a metabolically favourable phenotype resisting obesity and hyperglycaemia on a high-fat diet. Diabetologia 54:9, pages 2392-2403.
Crossref
Crossref
Huayuan Zhu, Juejin Wang, Jianyong Li & Shengnan Li. (2011) Corticotropin-releasing factor family and its receptors: pro-inflammatory or anti-inflammatory targets in the periphery?. Inflammation Research 60:8, pages 715-721.
Crossref
Crossref
Idoia Gamez, Robert P. Ryan, Lakesha D. Reid, Sheri M. Routt & Beth A. Hollister. (2010) Corticorelin acetate, a synthetic corticotropin-releasing factor with preclinical antitumor activity, alone and with bevacizumab, against human solid tumor models. Cancer Chemotherapy and Pharmacology 67:6, pages 1415-1422.
Crossref
Crossref
Alicia Arranz, Maria Venihaki, Berber Mol, Ariadne Androulidaki, Erini Dermitzaki, Olga Rassouli, Jorge Ripoll, Efstathios N Stathopoulos, Rosa P Gomariz, Andrew N Margioris & Christos Tsatsanis. (2010) The impact of stress on tumor growth: peripheral CRF mediates tumor-promoting effects of stress. Molecular Cancer 9:1.
Crossref
Crossref
Kuntal Pal, Kunchithapadam Swaminathan, H. Eric Xu & Augen A. Pioszak. (2010) Structural Basis for Hormone Recognition by the Human CRFR2α G Protein-coupled Receptor. Journal of Biological Chemistry 285:51, pages 40351-40361.
Crossref
Crossref
Kazunori Kageyama, Komaki Hanada & Toshihiro Suda. (2010) Differential regulation and roles of urocortins in human adrenal H295R cells. Regulatory Peptides 162:1-3, pages 18-25.
Crossref
Crossref
Konstantinos A. Paschos, Chara Charsou, Theodoros C. Constantinidis, Stavros Anagnostoulis, Maria Lambropoulou, Fotini Papachristou, Konstantinos Simopoulos & Ekaterini Chatzaki. (2010) Corticotropin-Releasing Hormone Receptors Mediate Opposing Effects in Cholestasis-Induced Liver Cell Apoptosis. Endocrinology 151:4, pages 1704-1712.
Crossref
Crossref
Athina Kaprara, Kalliopi Pazaitou-Panayiotou, Alexandros Kortsaris & Ekaterini Chatzaki. (2010) The corticotropin releasing factor system in cancer: expression and pathophysiological implications. Cellular and Molecular Life Sciences 67:8, pages 1293-1306.
Crossref
Crossref
Xing Gu, Peng Qi, Feiguo Zhou, Qiang Ji, Hao Wang, Tonghai Dou, Yunpeng Zhao & Chunfang Gao. (2009) An intronic polymorphism in the corticotropin-releasing hormone receptor 2 gene increases susceptibility to HBV-related hepatocellular carcinoma in Chinese population. Human Genetics 127:1, pages 75-81.
Crossref
Crossref
Sean M. Davidson & Derek M. Yellon. (2009) Urocortin: A Few Inflammatory Remarks. Endocrinology 150:12, pages 5205-5207.
Crossref
Crossref
Rihong Cong, Qingmin Sun, Li Yang, Haijuan Gu, Ying Zeng & Bin Wang. (2009) Effect of Genistein on vasculogenic mimicry formation by human uveal melanoma cells. Journal of Experimental & Clinical Cancer Research 28:1.
Crossref
Crossref
Hossein Tezval, Stefanie Jurk, Farahnaz Atschekzei, Jan U. Becker, Olaf Jahn, Jürgen Serth & Markus A. Kuczyk. (2009) Urocortin and corticotropin-releasing factor receptor 2 in human renal cell carcinoma: disruption of an endogenous inhibitor of angiogenesis and proliferation. World Journal of Urology 27:6.
Crossref
Crossref
Youhua Xu, Rongjian Zhang, Jie Chen, Qichun Zhang, Juejin Wang, Jue Hu, Xiaowei Guan, Lai Jin, Hong Fu, Bo Gui, Yuanyuan Guo & Shengnan Li. (2009) Urocortin promotes the development of vasculitis in a rat model of thromboangiitis obliterans via corticotrophin-releasing factor type 1 receptors. British Journal of Pharmacology 157:8, pages 1368-1379.
Crossref
Crossref
Xuan Li, Jue Hu, Qichun Zhang, Xiaoyu Sun & Shengnan Li. (2009) Urocortin 1 improves renal function in rats with streptozotocin‐induced diabetes by inhibiting overproduction of TGF‐β1 and VEGF. British Journal of Pharmacology 157:6, pages 994-1003.
Crossref
Crossref
Hossein Tezval, Steffanie Jurk, Farahnaz Atschekzei, Jürgen Serth, Markus A. Kuczyk & Axel S. Merseburger. (2008) The involvement of altered corticotropin releasing factor receptor 2 expression in prostate cancer due to alteration of anti‐angiogenic signaling pathways. The Prostate 69:4, pages 443-448.
Crossref
Crossref
Sean M. Davidson, Aneta E. Rybka & Paul A. Townsend. (2009) The powerful cardioprotective effects of urocortin and the corticotropin releasing hormone (CRH) family. Biochemical Pharmacology 77:2, pages 141-150.
Crossref
Crossref